PrEP, available as a daily pill or an injection every eight weeks, significantly reduces the risk of contracting HIV. As ...

Due to antiretroviral therapy, individuals with HIV are ageing and their risk for age-related comorbidities is increasing.

A new drug called lenacapavir might entirely change the game, though.

Health Minister Dr Aaron Motsoaledi revealed that South Africa intends to roll out lenacapavir, a revolutionary long-acting HIV prevention method that could transform public health as early as March ...

The 21-valent pneumococcal conjugate vaccine V116 is well tolerated in adults living with HIV and induces immunity to all 21 ...

Health Minister Dr Aaron Motsoaledi announced that the national rollout is expected to begin by March or April 2026, ...

New UKHSA data show a continued drop in HIV diagnoses and deaths across the UK, but experts warn that inequalities and gaps in testing remain.

Lenacapavir is a breakthrough long-acting HIV prevention drug, which Motsoaledi has labelled a turning point in the country’s ...

Kameron Gilchrest is charged with assaulting emergency personnel after allegedly spraying his HIV-positive blood at hospital ...

Those who had at least 1 inpatient insurance claim for HIV-related treatment or unrelated treatment with an HIV diagnosis were considered to be living with HIV. Receiving 1 or more opioid ...

The adult-specific 21-valent pneumococcal conjugate vaccine was well tolerated and immunogenic across all 21 serotypes in patients with HIV infection.